Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Licenses Callida Genomics DNA Chip Patents

NEW YORK, May 20-Agilent Technologies has signed a licensing agreement for access to Callida Genomics' portfolio of non-universal DNA microarray patents, the two companies said today.


Through the agreement, Agilent will have access to intellectual property protected by a set of patents on the work of Callida CSO Radoje Drmanac, who was involved in early microarray development.


Callida will receive both up-front fees and potential running royalties. The license is non-exclusive.


Callida Genomics, a majority owned subisidiary of Hyseq Pharmaceuticals, was launched last fall following the settlement of a major patent lawsuit between Affymetrix and Hyseq. Researchers at Callida are working to commercialize the sequencing-by-hybridization technology that Drmanac developed.


For more information about this agreement, click here.

The Scan

Gene Linked to Alkaline Sensitivity in Plants Identified

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.